论文部分内容阅读
近年来,国内外有不少报道使用前列腺素衍生物——米索前列醇(misoprostol,MP)引产,认为其促宫缩成熟作用及引产效果较好,但其最佳用药剂量、用药途径、是否适用于病理妊娠及其安全性仍存在争议。本文通过对80例晚期妊娠妇女,选用50μg剂量的MP分别采用阴道和肛门用药,并与催产素对照进行,临床观察,以对MP适宜剂量、用药方法、用药指征、引产效果及安全性进一步探讨。
In recent years, there are many reports at home and abroad using prostaglandin derivative misoprostol (misoprostol, MP) induction of labor, that its role in promoting uterine contractions and induction of labor is better, but the best dose, route of administration, Whether it is suitable for pathological pregnancy and its safety is still controversial. In this paper, 80 cases of late pregnancy women, the choice of 50μg dose of MP were used vaginal and anal drugs, and oxytocin control, clinical observation, in order to MP appropriate dosage, medication, medication indications, induction of labor and safety further Discussion.